跳至主要内容
临床试验/NCT03073824
NCT03073824已完成不适用

An Open-label Long-term Evaluation of a Novel Intravaginal Device in Female Patients Experiencing Sexual and Bladder Function Issues

Joylux, Inc.4 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2017年3月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Joylux, Inc.
入组人数
65
试验地点
4
主要终点
Improvement in Patient Quality of Life as Measured by Female Sexual Response Index

研究概览

简要总结

An open-label long-term evaluation of a novel intravaginal device in female patients experiencing sexual and bladder function issues.

详细描述

To determine the long-term clinical efficacy of the vSculpt therapy on treating the pelvic floor area and vaginal tissue for females who experience bladder and sexual dysfunction.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 59 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • All study participants are required to be biological females (genotype XX) to participate
  • Female participants will be of adult age, over 18
  • Female participants with self-reported concerns with bladder and sexual function
  • Female participants who have reliable and consistent computer and internet access on a daily basis

排除标准

  • Female participants shall not have an active sexually transmitted disease and/or infection
  • Female participants who are actively undergoing chemotherapy or radiation
  • Female participants who are currently taking any cancer-related or photosensitivity drugs
  • Female participants who are pregnant, who may think they are pregnant, and/or actively trying to get pregnant during the clinical study

研究组 & 干预措施

vSculpt, model #VS1100

Experimental

A novel intravaginal device for females

干预措施: vSculpt (Device)

结局指标

主要结局

Improvement in Patient Quality of Life as Measured by Female Sexual Response Index

时间窗: 365 days

Improvement in patient quality of life as measured by an improvement in Female Sexual Function Index (FSFI) scores.

Improvement in patient quality of life as measured by the Female Sexual Distress

时间窗: 365 days

Improvement in patient quality of life as measured by an improvement Female Sexual Distress Score (FSDS) scores.

Improvement in patient quality of life as measured by the Urogenital Distress Inventory, Short Form (UDI-6)

时间窗: 365 days

Improvement in patient quality of life as measured by an improvement Urogenital Distress Inventory, Short Form (UDI-6) scores.

Improvement in patient quality of life as measured by the Incontinence Impact Questionnaire, Short Form (IIQ-7)

时间窗: 365 days

Improvement in patient quality of life as measured by an improvement Incontinence Impact Questionnaire, Short Form (IIQ-7) scores.

次要结局

未报告次要终点

研究者

发起方
Joylux, Inc.
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验